Impact of empagliflozin on quality-of-life in real-world patients with heart failure: insights from the multinational Emp-Activity study

Back

ESC2025 Premium Access

Impact of empagliflozin on quality-of-life in real-world patients with heart failure: insights from the multinational Emp-Activity study

Session: Evolving strategies in heart failure management

Topic: Pharmacotherapy

Speaker: Professor A. Tomaszuk-Kazberuk (Bialystok, PL)

Event: ESC Congress 2025

Congress Presentation

Add to my library

About the speaker

Professor Anna Tomaszuk-Kazberuk

Medical University of Bialystok, Bialystok (Poland)

2 presentations

0 follower

5 more presentations in this session

Integrated multi-omic response to heart failure reverse remodeling with left ventricular assist device

Speaker: Doctor X. Xu (Beijing, CN)

Impact of coronary revascularisation in patients undergoing cardiovascular magnetic resonance for viability assessment

Speaker: Doctor A. Lequipar (Paris, FR)

Assessing impact of home-based digital cardiac rehabilitation on readmissions and patient outcomes following step-down from the acute heart failure virtual ward

Speaker: Doctor D. Duvva (Liverpool, GB) Doctor R. Sankaranarayanan (Liverpool, GB)

The antifibrotic effect of novel heart failure pharmacotherapies in myocardial samples of patients undergoing heart transplantation

Speaker: Doctor D. Nagy (Budapest, HU)

MAGGIC in the machine: unveiling the predictive value of a conventional risk score in the ultra-long LVAD phenotype. Insights from the STELLAR register.

Speaker: Doctor C. Velasquez-Silva (Bad Oeynhausen, DE)

Access the full session

Evolving strategies in heart failure management

Speakers: Professor A. Tomaszuk-Kazberuk, Doctor X. Xu, Doctor A. Lequipar, Doctor D. Duvva, Doctor R. Sankaranarayanan...

Access

Video

About the event

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources

Explore sponsored resources